It is important to note that off-label prescribing of these medications as weight loss drugs should be discussed with a healthcare provider
Any pharmacological intervention should be discussed with a healthcare provider
What is genuinely exciting, and worth watching closely, is the growing body of evidence that metabolic health optimization has measurable impacts on autoimmune disease burden
However, there is currently no high-quality clinical evidence proving the safety or effectiveness of this combination, so any peptide use should only be considered with clinical supervision
Clinically, BPC-157 is best suited for acute and subacute soft-tissue injuries, including tendon, ligament, muscle, fascia, and periarticular soft-tissue problems